Schedule 13G ownership disclosure

aTyr Pharma Inc

COMMON STOCK · CUSIP: 002120202

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Federated Hermes, Inc.

    Shares: 10,544,437.00 · Class: 10.76%

  • Voting Shares Irrevocable Trust

    Shares: 10,544,437.00 · Class: 10.76%

  • Thomas R. Donahue

    Shares: 10,544,437.00 · Class: 10.76%

  • Ann C. Donahue

    Shares: 10,544,437.00 · Class: 10.76%

  • J. Christopher Donahue

    Shares: 10,544,437.00 · Class: 10.76%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-25-001385
Form type
SCHEDULE 13G/A
Filer
FEDERATED HERMES, INC.
CIK
CIK 1056288
Filed
Oct 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub